A human immunoglobulin G1 antibody originating from an in vitro-selected Fab phage antibody binds avidly to tumor-associated MUC1 and is efficiently internalized

American Journal of Pathology

Volumn 160, Issue 5, 2002, Pages 1597-1608

  Henderikx, Paula ^a   Neer, Nicole Coolen Van ^a   Jacobs, Anita ^a   Van Der Linden, Edith ^b   Arends, Jan Willem ^b   Müllberg, Jürgen ^a   Hoogenboom, Hennie R ^a,b  

^a Building 22   (Belgium)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; MUCIN 1;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; COLON CARCINOMA; FIBROBLAST; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INTERNALIZATION; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; TANDEM REPEAT;

EID: 0036098248     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)61107-8     Document Type: Article

References (43)

1. Overview of the clinical development of rituximab: First monoclonal antibody approved for the treatment of lymphoma
2. Monoclonal antibody therapy for resected Dukes' C colorectal cancer: Seven-year outcome of a multicenter randomized trial
3. Clinical trials of Herceptin (trastuzumab)
4. A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats
5. MUC1 and cancer
6. Tissue and tumor distribution of human polymorphic epithelial mucin
7. Building antibodies from their genes
8. Creating and engineering human antibodies for immunotherapy
9. Towards a network theory of the immune system
10. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: Modulation of the immunogenicity in patients with malignant melanoma
11. Activation of cellular immunity after intracavitary monoclonal antibody therapy of ovarian cancer
12. A large nonimmunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies
13. An integrated vector system for the eukaryotic expression of antibodies or their fragments after selection from phage display libraries
14. Radioimmunotherapy after chemotherapy compared to chemotherapy alone in the treatment of advanced ovarian cancer: A matched analysis
15. Human single-chain Fv antibodies to MUC1 core peptide selected from phage display libraries recognize unique epitopes and predominantly bind adenocarcinoma
16. A factor preventing the major head protein of bacteriophage T4 from random aggregation
17. An enzyme-linked immunosorbent assay for the measurement of circulating antibodies to polymorphic epithelial mucin (MUC1)
18. Vaccinia virus MUC1 immunization of mice: Immune response and protection against the growth of murine tumors bearing the MUC1 antigen
19. Expression of a glycoprotein of the carcinoembryonic antigen family in normal and neoplastic sebaceous glands. Limited role of carcinoembryonic antigen as a sweat gland marker
20. Immunohistochemical characterization of a panel of 56 antibodies with normal human small intestine, colon, and breast tissues
21. Epitope-dependent differential immunoreactivities of anti-MUC1 monoclonal antibodies in human carcinomas
22. Comparison of the biological properties of two anti-mucin-1 antibodies prepared for imaging and therapy
23. Targeting of bivalent anti-ErbB2 diabody antibody fragments to tumor cells is independent of the intrinsic antibody affinity
24. Effect of modification of carbohydrate side chains on the reactivity of antibodies with core-protein epitopes of the MUC1 gene product
25. Reactivity of antibodies with highly glycosylated MUC1 mucins from colon carcinoma cells and bile
26. Epitope characterization of MUC1 antibodies
27. MUC1 glycoforms in breast cancer - Cell line T47D as a model for carcinoma-associated alterations of O-glycosylation
28. Structure/activity studies of the anti-MUC1 monoclonal antibody C595 and synthetic MUC1 mucincore-related peptides and glycopeptides
29. Biodistribution of (111)indium-labeled engineered human antibody CTMO1 in ovarian cancer patients: Influence of protein dose
30. Diagnosis of breast carcinoma with radiolabeled monoclonal antibodies (MoAbs) to carcinoembryonic antigen (CEA) and human milk fat globulin (HMFG)
31. 99mTc-labelled SM3 in the preoperative evaluation of axillary lymph nodes and primary breast cancer with change detection statistical processing as an aid to tumour detection
32. Initial clinical evaluation of radiolabeled MX-DTPA humanized BrE-3 antibody in patients with advanced breast cancer
33. Symonds: Biodistribution of (111)indium-labeled engineered human antibody CTMO1 in ovarian cancer patients: Influence of protein dose
34. Radioimmunotherapy for breast cancer using indium-111/yttrium-90 BrE-3: Results of a phase I clinical trial
35. The combined use of an immunotoxin and a radioimmunoconjugate to treat disseminated human B-cell lymphoma in immunodeficient mice
36. Immunocytokines: A promising approach to cancer immunotherapy
37. Endocytosis and intracellular routing of an antibody-ricin A chain conjugate
38. The epithelial sialomucin, episialin, is sialylated during recycling
39. A review of modifications to recombinant antibodies: Attempt to increase efficacy in oncology applications
40. Use of monoclonal antibodies for the diagnosis and treatment of bladder cancer
41. Immunoscintigraphy of small-cell lung cancer xenografts with anti neural cell adhesion molecule monoclonal antibody, 123C3: Improvement of tumour uptake by internalisation
42. Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells
43. Recombinant immunocytokines targeting the mouse transferrin receptor: Construction and biological activities